Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus

Clinical Rheumatology

Volumn 34, Issue 3, 2015, Pages 471-477

  Li, Hejun ^a   Lin, Shunping ^a   Yang, Shangchih ^b   Chen, Ling ^a   Zheng, Xiangxiong ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b Chang Gung Memorial Hospital   (China)

Author keywords

Antinuclear antibody; Complement; Diagnostic value; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CHINESE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HEMATOLOGIC DISEASE; HUMAN; HYPOCOMPLEMENTEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CHINA; COMPLEMENT C3; COMPLEMENT C4; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84925482266     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2843-4     Document Type: Article

References (19)

1. Gu YY (2012) Systemic lupus erythematosus. In: Wang JY, Liao EY, Huang CX, Hua Q (eds) Internal medicine, 2nd edn. People’s Medical Publishing House, Beijing, pp 1115–1123
2. Liu CC, Ahearn JM (2009) The search for lupus biomarkers. Best Pract Res Clin Rheumatol 23:507–523
3. Petri M, Systemic Lupus International Collaborating Clinic (SLICC) (2009) SLICC revision of the ACR classification criteria for SLE [abstract]. Arthritis Rheum 60:895
4. Li J, An L, Zhang Z (2014) Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus. Clin Exp Rheumatol 32:48–53
5. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfeld NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
6. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725
7. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686
8. Julkunen H, Ekblom-Kullberg S, Miettinen A (2012) Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4. Rheumatol Int 32:2445–2451
9. Andrejevic S, Jeremic I, Sefik-Bukilica M, Nikolic M, Stojimirovic B, Bonaci-Nikolic B (2013) Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity. Clin Rheumatol 32(11):1619–1626
10. Swaak AJ, Groenwold J, Bronsveld W (1986) Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 45:359–366
11. Clowse ME, Magder LS, Petri M (2011) The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. J Rheumatol 38:1012–1016
12. Kiani AN, Vogel-Claussen J, Magder LS, Petri M (2010) Noncalcified coronary plaque in systemic lupus erythematosus. J Rheumatol 37:579–584
13. Li J, An L, Zhang Z (2014) Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus. Clin Exp Rheumatol Exp Rheumatol 32(1):48–53
14. Kalunian KC, Chatham WW, Massarotti EM, Reyes-Thomas J, Harris C, Furie RA et al (2012) Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus. Arthritis Rheum 64(12):4040–4047
15. Ricker DM, Hebert LA, Rohde R, Sedmak DD, Lewis EJ, Clough JD, The Lupus Nephritis Collaborative Study Group (1991) Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. Am J Kidney Dis 18:678–685
16. Borba EF, Araujo DB, Bonfá E, Shinjo SK (2013) Clinical and immunological features of 888 Brazilian systemic lupus patients from a monocentric cohort: comparison with other populations. Lupus 22:744–749
17. Ekwom PE (2013) Systemic lupus erythematosus (SLE) at the Kenyatta National Hospital. Clin Rheumatol 32:1215–1217
18. Bruner BF, Guthridge JM, Lu R, Vidal G, Kelly JA, Robertson JM et al (2012) Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members. Arthritis Rheum 64:3677–3686
19. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ et al (1997) Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum 40:1601–1611